Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Seminars in Thrombosis and Hemostasis|March 31, 2012
FEIBA: a prohemostatic agentCaroline Cromwell, Louis M AledortSeminars in Thrombosis and Hemostasis|March 18, 2003
Orthopedic outcome studies and cost issuesLouis M AledortPathophysiology of Haemostasis and Thrombosis|July 11, 2003
Why thrombin generation? From bench to bedsideLouis M AledortAmerican Journal of Hematology|November 30, 2005
United States' factor XI-deficiency patients need a safer treatmentLouis M Aledort, Jenny Goudemand, Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Advances in clotting factor treatment for congenital hemorrhagic disordersMichael D Tarantino, Louis M AledortAmerican Journal of Hematology|November 24, 2004
Factors affecting choice of hemostatic agent for the hemophilia patient with an inhibitor antibodyPaul E Monahan, Louis M Aledort, The Mount Sinai Journal of Medicine, New York|May 26, 2005
Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategiesSebastian A Mayer, Louis M AledortExpert Review of Hematology|June 21, 2013
Restoring hemostasis: fibrinogen concentrate versus cryoprecipitateBrian M Elliott, Louis M AledortAmerican Journal of Hematology|June 7, 2006
Echinocytosis--an unusual manifestation of hemangiomaIvy Altomare, Garrett Desman, Louis M AledortThrombosis Journal|October 19, 2007
The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literatureIvy Altomare, Alan Adler, Louis M AledortPageof 4